Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters











Database
Language
Publication year range
1.
J Neuroimmunol ; 370: 577918, 2022 09 15.
Article in English | MEDLINE | ID: mdl-35853356

ABSTRACT

OBJECTIVES: To report two pediatric cases of autoimmune cerebellar ataxia associated with the anti-Leucine-rich glioma-inactivated protein 1 (LGI1)antibodies. METHODS: The clinical features of the two patients were described retrospectively. The indirect immunofluorescence using transfected cells (cell-based assay, CBA) and the rat cerebellum (tissue-based assay, TBA) with the multi-antigen co-plate biochip mosaic techniques were used to detect the antibodies. Clinical and laboratory characteristics were described. RESULTS: Two males were included. The onset ages were 2.7y and 4y, respectively. Patient 1 manifested as isolated acute cerebellar ataxia. Patient 2 had extra-cerebellar symptoms, including seizures, encephalopathy, faciobrachial dystonic seizures(FBDs), and significant cerebellar ataxia. The hyponatremia and tumors were not found. Both of them responded well to the immunotherapy. CONCLUSIONS: The autoimmune cerebellar ataxia might be a new phenotype of LGI1-Abs autoimmunity in children.


Subject(s)
Cerebellar Ataxia , Glioma , Limbic Encephalitis , Antibodies , Autoantibodies , Cerebellar Ataxia/complications , Glioma/complications , Humans , Intracellular Signaling Peptides and Proteins , Leucine/therapeutic use , Male , Retrospective Studies , Seizures/drug therapy
SELECTION OF CITATIONS
SEARCH DETAIL